Shilpa Medicare Appoints Veteran Dr Uday N Harle as CEO of Shilpa Biologicals Written By Parthika Patel4 Aug 2026 7:41 PM ISTHyderabad: Shilpa Medicare Limited has announced the appointment of Dr Uday N Harle as the Chief Executive Officer (CEO) of Shilpa Biologicals Private...
Shilpa Biologicals CEO Dr Sridevi Khambhampaty Resigns Written By Medical Dialogues Team16 July 2026 8:10 PM ISTHyderabad: Shilpa Medicare Limited has informed the stock exchanges that Dr Sridevi Khambhampaty has resigned as Chief Executive Officer (CEO) of its...
Shilpa Biologicals Signs Europe Deal with Orion for Cancer Drug Nivolumab Biosimilar Written By Parthika Patel30 Jun 2026 6:35 PM ISTNew Delhi: Shilpa Biologicals Private Limited (SBPL), a wholly owned subsidiary of Shilpa Medicare Limited, has entered into a co-development and...
Shilpa Biologicals Pays Rs 9 Crore to Settle Commercial Dispute with Sartorius India Written By Parthika Patel26 Jun 2026 5:01 PM ISTNew Delhi: Shilpa Medicare Limited has informed the stock exchanges that its material subsidiary, Shilpa Biologicals Pvt. Ltd., has entered into a...
Shilpa Biologicals Launches Advanced ADC Manufacturing Facility in Dharwad Written By Parthika Patel25 Jun 2026 12:42 PM ISTNew Delhi: Shilpa Biologicals Pvt. Ltd., a material subsidiary of Shilpa Medicare Ltd, has announced the commissioning of a state-of-the-art...
Shilpa Medicare Unit Invests Euro 7 Million in Brain Cancer Drug Developer Gate2Brain Written By Parthika Patel5 Jun 2026 4:17 PM ISTNew Delhi: Shilpa Biocare Pvt Ltd, a wholly owned subsidiary of Shilpa Medicare Limited, has announced a strategic equity partnership with...
Shilpa Medicare's Bengaluru Unit Receives 5 USFDA Observations Following PAI Written By Parthika Patel1 Jun 2026 11:36 PM ISTHyderabad: Shilpa Medicare Limited has announced that the United States Food and Drug Administration (USFDA) conducted a Pre-Approval Inspection (PAI)...
Shilpa Medicare Names Pharma Veteran Vellaian Karuppiah as COO, Formulations Written By Parthika Patel25 April 2026 5:25 PM ISTNew Delhi: Shilpa Medicare Limited has appointed Dr Vellaian Karuppiah as Chief Operating Officer (COO), Formulations with effect from April 23, 2026,...
NCLT Approves Merger of Shilpa Therapeutics with Shilpa Medicare Written By Parthika Patel21 March 2026 11:45 AM ISTNew Delhi: Shilpa Medicare Limited has received approval from the National Company Law Tribunal (NCLT), Bengaluru Bench, for the amalgamation of its...
Shilpa Biologicals, Stein Cares Ink Exclusive Biosimilar Licensing Pact for Latin America Written By sheeba farhat25 Feb 2026 2:35 PM ISTNew Delhi: Stein Cares, a specialty healthcare company in Latin America, and Shilpa Biologicals Pvt. Ltd., a fully integrated biopharmaceutical...
Shilpa Medicare Partners NXI Therapeutics for Autoimmune Therapy Development, Manufacturing Written By Susmita Roy15 Feb 2026 1:45 PM ISTNew Delhi: Shilpa Medicare has announced the strategic partnership for a long-term development and commercial manufacturing agreement with NXI...
Shilpa Medicare Enters US Transdermal Market, Files First ANDA for Rotigotine Patch Written By sheeba farhat8 Feb 2026 12:00 PM ISTNew Delhi: Shilpa Medicare Limited has informed stock exchanges that it has filed an Abbreviated New Drug Application (ANDA) with the United States...
